Skip to main content

LogicBio Therapeutics, Inc. (NASDAQ: LOGC) Investor Securities Class Action Lawsuit 03/19/2020

  • If you purchased shares of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April 5, 2021 - The case was voluntarily dismissed. June 2, 2020 - The case was transferred to the U.S. District Court for the District of Massachusetts. March 18, 2020 - An investor in shares of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by LogicBio Therapeutic...



You must register (for free) or login to view the entire case.